Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05775484

Exercise to Slow Cardiovascular Ageing Progression

Status
Recruiting
Phase
Study type
Observational
Enrollment
450 (estimated)
Sponsor
National Heart Centre Singapore · Academic / Other
Sex
All
Age
21 Years – 100 Years
Healthy volunteers
Accepted

Summary

In ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modification of these metabolites by intervention, such as exercise, may retard CV alterations and reduce CVD in ageing.

Detailed description

Participants from each stratum will be randomized to receive either an exercise program intervention or no exercise. At the start and end of study, participants will undergo cardiovascular imaging and metabolic profiling. Investigators will determine if exercise can reverse high-risk metabolic profiles and improve cardiovascular structure and function. Without clear mechanisms to explain cardiovascular ageing nor interventions known to retard cardiovascular ageing, our approach will provide much needed translational evidence to incorporate targeted interventions aimed at reducing cardiovascular disease risk in older populations.

Conditions

Timeline

Start date
2023-05-01
Primary completion
2026-12-31
Completion
2050-12-31
First posted
2023-03-20
Last updated
2025-06-05

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05775484. Inclusion in this directory is not an endorsement.